...
首页> 外文期刊>Surgical Endoscopy >Morbidity and mortality in complex robot-assisted hiatal hernia surgery: 7-year experience in a high-volume center
【24h】

Morbidity and mortality in complex robot-assisted hiatal hernia surgery: 7-year experience in a high-volume center

机译:复杂机器人辅助性疝疝气手术中的发病率和死亡率:高批量中心7年的经验

获取原文
获取原文并翻译 | 示例
           

摘要

IntroductionPublished data regarding robot-assisted hiatal hernia repair are mainly limited to small cohorts. This study aimed to provide information on the morbidity and mortality of robot-assisted complex hiatal hernia repair and redo anti-reflux surgery in a high-volume center.Materials and methodsAll patients that underwent robot-assisted hiatal hernia repair, redo hiatal hernia repair, and anti-reflux surgery between 2011 and 2017at the Meander Medical Centre, Amersfoort, the Netherlands were evaluated. Primary endpoints were 30-day morbidity and mortality. Major complications were defined as Clavien-DindoIIIb.ResultsPrimary surgery 211 primary surgeries were performed by two surgeons. The median age was 67 (IQR 58-73) years. 84.4% of patients had a type III or IV hernia (10.9% Type I; 1.4% Type II; 45.5% Type III; 38.9% Type IV, 1.4% no herniation). In 3.3% of procedures, conversion was required. 17.1% of patients experienced complications. The incidence of major complications was 5.2%. Ten patients (4.7%) were readmitted within 30days. Symptomatic early recurrence occurred in two patients (0.9%). The 30-day mortality was 0.9%. Redo surgery 151 redo procedures were performed by two surgeons. The median age was 60 (IQR 51-68) years. In 2.0%, the procedure was converted. The overall incidence of complications was 10.6%, while the incidence of major complications was 2.6%. Three patients (2.0%) were readmitted within 30days. One patient (0.7%) experienced symptomatic early recurrence. No patients died in the 30-day postoperative period.ConclusionsThis study provides valuable information on robot-assisted laparoscopic repair of primary or recurrent hiatal hernia and anti-reflux surgery for both patient and surgeon. Serious morbidity of 5.2% in primary surgery and 2.6% in redo surgery, in this large series with a high surgeon caseload, has to be outweighed by the gain in quality of life or relief of serious medical implications of hiatal hernia when counseling for surgical intervention.
机译:关于机器人辅助的海拔Hernia修复的简介数据主要限于小型队列。本研究旨在提供关于机器人辅助复合物疝修复和重做抗反动手术的发病率和死亡率的信息。在高批量中心的方法和方法所有患者接受了机器人辅助性疝修补,重做HERTAL HERNIA修复,和2011年和2017年之间的抗反流手术在北部和2017年间,荷兰的蜿蜒医疗中心,Amersfoort进行了评估。主要终点为30天的发病率和死亡率。主要并发症被定义为Clavien-Dindoiib.Resultsprimary手术211初级手术由两个外科医生进行。中位年龄为67(IQR 58-73)年。 84.4%的患者患有III型或IV疝(10.9%I型; 1.4%II型; III型45.5%; 38.9%型IV型,1.4%无枢过1.4%)。在3.3%的程序中,需要转换。 17.1%的患者经历了并发症。主要并发症的发生率为5.2%。 10名患者(4.7%)在30天内被预约。症状早期复发发生在两名患者(0.9%)。 30天死亡率为0.9%。重做手术151重做程序由两个外科医生进行。中位年龄为60(IQR 51-68)年。在2.0%,该过程已转换。并发症的总体发生率为10.6%,而主要并发症的发病率为2.6%。三名患者(2.0%)在30天内被重新提出。一名患者(0.7%)经历过症状早期复发。没有患者在术后30天死亡.Conclusionsthis研究提供了有关患者和外科医生的主要或复发性海藻疝和抗回流手术的机器人辅助腹腔镜修复有价值的信息。在初级手术中的严重发病率为5.2%,在这一大型外科队的大型系列中,在这一大型外科队的大型系列中,必须超过生命质量的收益或在咨询外科手术干预时占生命质量或缓解严重医疗影响的增长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号